Galapagos Sasu
Records under this name other than patents Galapagos Sasu holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,415,037 | Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases conveyed to Galapagos N.V. - now held by Alfasigma S.P.A. In force · High confidence | In force | High confidence | |
| US 10,206,907 | Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases conveyed to Galapagos N.V. - now held by Alfasigma S.P.A. In force · High confidence | In force | High confidence | |
| US 8,853,240 | Novel Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases now held by Alfasigma S.P.A. In force · High confidence | In force | High confidence | |
| US 10,259,810 | N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-Carboxamides AND METHOD OF USE conveyed to Galapagos N.V. In force · High confidence | In force | High confidence | |
| US 10,829,473 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd. In force · High confidence | In force | High confidence | |
| US 10,844,041 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd. In force · High confidence | In force | High confidence | |
| US 10,844,042 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd. In force · High confidence | In force | High confidence | |
| US 10,981,890 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd. In force · High confidence | In force | High confidence | |
| US 10,988,454 | Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use conveyed to Galapagos N.V. - now held by AbbVie Global Enterprises Ltd. In force · High confidence | In force | High confidence | |
| US 11,564,923 | Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders conveyed to Galapagos N.V. - now held by Lakefront Biotherapeutics In force · High confidence | In force | High confidence |